The orthopedic market is healthier than it’s been in years. In this video, we take a look at three things we might learn during company earnings reports for the fourth quarter of 2024. Are the higher growth rates a durable tailwind? Which companies have the most to prove? What trends will we see for technology uptake?
Mike Evers is an analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage. You can reach him by email.
The orthopedic market is healthier than it’s been in years. In this video, we take a look at three things we might learn during company earnings reports for the fourth quarter of 2024. Are the higher growth rates a durable tailwind? Which companies have the most to prove? What trends will we see...
The orthopedic market is healthier than it’s been in years. In this video, we take a look at three things we might learn during company earnings reports for the fourth quarter of 2024. Are the higher growth rates a durable tailwind? Which companies have the most to prove? What trends will we see for technology uptake?
Mike Evers is an analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage. You can reach him by email.
You are out of free videos for this month
Subscribe as a Guest for $0 and unlock a total of 5 videos per month.
You are out of five videos for this month
Subscribe as an Executive Member for access to unlimited videos, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.